2013 American Transplant Congress
First Case of Using Eculizumab To Salvage Antibody Mediated Rejection in a Highly Desensitization-Resistant Intestinal Re-Transplant Patient, The
Univ of Miami, Miami; CCF, Cleveland
The antibody mediated rejection (AMR) in intestinal transplantation may lead to graft loss. High titer of panel reactive antibody (PRA) and donor specific antibody (DSA)…2013 American Transplant Congress
Characteristics of Abdominal Wall Rejection after Intestinal and Abdominal Wall Transplantation
Churchill Hospital, Oxford, United Kingdom
Aim:To report our experience of abdominal wall graft rejection after abdominal wall transplant.Methods:Retrospective case notes analysis of all patients undergoing combined intestinal and abdominal wall…2013 American Transplant Congress
Is Dysfunction of the HNF-1 Beta Gene Involved in the Pathogenesis of New-Onset Diabetes after Transplantation?
Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Background: A dysfunction of the HNF-1beta gene can lead to renal loss of magnesium, hyperuricemia and diabetes mellitus. There is a striking similarity between this…2013 American Transplant Congress
Reducing HIV / HCV Infection Transmission from Organ Transplantation through Nucleic Acid Testing of All Potential Deceased Donors: A Cost-Effectiveness Analysis
Background: Compared to antibody (Ab) tests, nucleic acid-amplification tests (NAT) shorten the window period during which HIV/HCV infection cannot be detected. We aimed to evaluate…2013 American Transplant Congress
Histology One Year Post-Kidney Transplant Relates to Risk of Alloimmune-Mediated Graft Failure Long Term
Introduction. One year protocol biopsies (PBx) distinguish a large group of grafts with normal histology/mild fibrosis (GIF) and low risk of failure (LwR) from a…2013 American Transplant Congress
Sterile Leukocyturia Predicts Interstitial Fibrosis and Tubular Atrophy in Kidney Allograft Protocol Biopsies
In kidney allograft protocol biopsies the presence of interstitial fibrosis and tubular atrophy (IF/TA) is associated with graft loss. In this study we sought to…2013 American Transplant Congress
Impact of Anatomical Variations and Insufficient Liver Volume on Living Liver Donation, The
Background and Aims: Organ shortage has been the ongoing obstacle to expand liver transplantation world-wide including Saudi Arabia. Living donor liver transplantation (LDLT) was hoped…2013 American Transplant Congress
Project NOTIFY: A Global Database of Serious Adverse Events and Reactions in Organs, Tissues, and Cells
Background: Serious adverse reactions and events (SAREs) are a threat to the safety and outcome of transplantation. World Health Assembly Resolution WHA 63.22 urges Member…2013 American Transplant Congress
Pharmacokinetics of Voclosporin (VCS) in Renal Impairment, The
Isotechnika Pharma Inc, Edmonton, Canada
Objective:To determine the pharmacokinetic profile of VCS in subjects with renal impairment.Methods:VCS 0.4 mg/kg was administered to subjects with Normal, Mild, Moderate, or Severe renal…2013 American Transplant Congress
Intrahepatic Cholangiocarcinoma (I-CC) or Mixed Hepatocellular-Cholangiocarcinoma (HCC-CC) in Patients Undergoing Liver Transplantation (LT). A Spanish Case Control Multicenter Study
Aim: to evaluate the outcome of patients with HCC-CC or I-CC at explant pathology after LT for suspected HCC.Methods:A case-control study 1:2. Study group(n=42) formed…
- « Previous Page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- …
- 178
- Next Page »